Recent

% | $
Quotes you view appear here for quick access.

AcelRx Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • transitionalximes transitionalximes Dec 4, 2012 6:21 PM Flag

    sec filing states phase 3 results Delayed until Q1 2013 in Prospectus filing

     

    Page 1 in the sec filing . Table of contents.
    " In November 2012, we reported top-line data showing that the primary endpoint of non-inferiority was met in an open-label active-comparator Phase 3 trial for our lead product candidate, the NanoTab System. We are also conducting two placebo-controlled efficacy and safety Phase 3 clinical trials for the NanoTab System, the first trial in patients with post-operative pain following open-abdominal surgery and the second trial in patients with post-operative pain following hip and knee replacement surgeries. We expect top-line data from both placebo-controlled efficacy and safety Phase 3 trials in the first quarter of 2013."

    Sentiment: Strong Buy

    This topic is deleted.
 
ACRX
3.89+0.17(+4.57%)Sep 30 4:00 PMEDT